BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 25983283)

  • 1. [Two-year incidence of new immune-mediated inflammatory diseases in patients with inflammatory bowel disease: A study in the AQUILES cohort].
    Marín-Jiménez I; Gisbert JP; Pérez-Calle JL; García-Sánchez V; Tabernero S; García-Vicuña R; Romero C; Juliá B; Vanaclocha F; Cea-Calvo L;
    Gastroenterol Hepatol; 2015 Dec; 38(10):569-74. PubMed ID: 25983283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immune-mediated inflammatory diseases in patients with inflammatory bowel disease. Baseline data from the Aquiles study].
    Marín-Jiménez I; García Sánchez V; Gisbert JP; Lázaro Pérez Calle J; Luján M; Gordillo Ábalos J; Tabernero S; Juliá B; Romero C; Cea-Calvo L; García-Vicuña R; Vanaclocha F
    Gastroenterol Hepatol; 2014 Nov; 37(9):495-502. PubMed ID: 24717523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-year incidence of psoriasis, uveitis and inflammatory bowel disease in patients with spondyloarthritis: A study in the AQUILES cohort.
    García-Vicuña R; Zarco P; González CM; Vanaclocha F; Marín-Jiménez I; Cea-Calvo L
    Reumatol Clin; 2016; 12(1):22-6. PubMed ID: 25683367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extra-articular disease in patients with spondyloarthritis. Baseline characteristics of the spondyloarthritis cohort of the AQUILES study.
    Zarco P; González CM; Rodríguez de la Serna A; Peiró E; Mateo I; Linares L; Calvo J; Cea-Calvo L; Arteaga MJ; Vanaclocha F; Marín-Jiménez I; García-Vicuña R
    Reumatol Clin; 2015; 11(2):83-9. PubMed ID: 25441489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and phenotype at diagnosis of inflammatory bowel disease. Results in Spain of the EpiCom study.
    Fernández A; Hernández V; Martínez-Ares D; Sanromán L; de Castro ML; Pineda JR; Carmona A; González-Portela C; Salgado C; Martínez-Cadilla J; Pereira S; García-Burriel JI; Vázquez S; Rodríguez-Prada I;
    Gastroenterol Hepatol; 2015 Nov; 38(9):534-40. PubMed ID: 25890448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and factors associated with uveitis in spondylarthritis patients in France: results from an observational survey.
    Canouï-Poitrine F; Lekpa FK; Farrenq V; Boissinot V; Hacquard-Bouder C; Comet D; Bastuji-Garin S; Thibout E; Claudepierre P
    Arthritis Care Res (Hoboken); 2012 Jun; 64(6):919-24. PubMed ID: 22262475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune-mediated inflammatory diseases and other comorbidities in patients with psoriasis: baseline characteristics of patients in the AQUILES study.
    Vanaclocha F; Crespo-Erchiga V; Jiménez-Puya R; Puig L; Sánchez-Carazo JL; Ferrán M; Sancho C; Juliá B; Cea-Calvo L; Marín-Jiménez I; García-Vicuña R;
    Actas Dermosifiliogr; 2015; 106(1):35-43. PubMed ID: 25091923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case-control Study on Dactylitis, Enthesitis, and Anterior Uveitis in Spondyloarthritis Associated with Inflammatory Bowel Diseases: Role of Coexistent Psoriasis.
    Cantini F; Niccoli L; Nannini C; Cassarà E; Kaloudi O; Rizzello F; Gionchetti P
    J Rheumatol; 2017 Sep; 44(9):1341-1346. PubMed ID: 28412702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immune-Mediated Inflammatory Diseases and accompanying comorbidities].
    Majdan M
    Wiad Lek; 2016; 69(4):611-615. PubMed ID: 27941197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study.
    Ott C; Obermeier F; Thieler S; Kemptner D; Bauer A; Schölmerich J; Rogler G; Timmer A
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):917-23. PubMed ID: 18794607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular Manifestations in Inflammatory Bowel Disease Are Associated with Other Extra-intestinal Manifestations, Gender, and Genes Implicated in Other Immune-related Traits.
    Taleban S; Li D; Targan SR; Ippoliti A; Brant SR; Cho JH; Duerr RH; Rioux JD; Silverberg MS; Vasiliauskas EA; Rotter JI; Haritunians T; Shih DQ; Dubinsky M; Melmed GY; McGovern DP
    J Crohns Colitis; 2016 Jan; 10(1):43-9. PubMed ID: 26449790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort.
    Vavricka SR; Brun L; Ballabeni P; Pittet V; Prinz Vavricka BM; Zeitz J; Rogler G; Schoepfer AM
    Am J Gastroenterol; 2011 Jan; 106(1):110-9. PubMed ID: 20808297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of uveitis and inflammatory bowel disease in people with psoriatic arthritis: a population-based cohort study.
    Charlton R; Green A; Shaddick G; Snowball J; Nightingale A; Tillett W; Smith CH; McHugh N;
    Ann Rheum Dis; 2018 Feb; 77(2):277-280. PubMed ID: 29092855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of inflammatory bowel disease in the 02 health area of Castellon (1992-1996).
    Monferrer Guardiola R; Martín Jiménez JA; Pedraza Sanz RG; Moreno Sánchez I; Soler Bahilo E; Hinojosa del Val J
    Rev Esp Enferm Dig; 1999 Jan; 91(1):33-46. PubMed ID: 10089786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and prevalence of extraintestinal manifestations in a cohort of patients with inflammatory intestinal disease in Medellin, Colombia.
    Juliao-Baños F; Arrubla M; Osorio L; Camargo J; Londoño J; Cáceres C; Carvajal J; Mosquera-Klinger G; Donado J
    Gastroenterol Hepatol; 2021; 44(6):398-404. PubMed ID: 33172691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The risk of colorectal cancer in patients with inflammatory bowel diseases in Finland: a follow-up of 20 years.
    Manninen P; Karvonen AL; Huhtala H; Aitola P; Hyöty M; Nieminen I; Hemminki H; Collin P
    J Crohns Colitis; 2013 Dec; 7(11):e551-7. PubMed ID: 23619008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extra-Gastrointestinal Manifestations of Inflammatory Bowel Disease May Be Less Common Than Previously Reported.
    Card TR; Langan SM; Chu TP
    Dig Dis Sci; 2016 Sep; 61(9):2619-26. PubMed ID: 27193564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Risk of Later Diagnosis of Inflammatory Bowel Disease in Patients With Dermatological Disorders Associated With Inflammatory Bowel Disease.
    King D; Chandan JS; Thomas T; Nirantharakumar K; Reulen RC; Adderley NJ; Trudgill N
    Inflamm Bowel Dis; 2021 Oct; 27(11):1731-1739. PubMed ID: 34669933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Incidence of inflammatory bowel diseases in the department of Puy-de-Dôme in 1993 and 1994. EPIMICI. Epidémiologie des Maladies Inflammatoires Cryptogenetiques de l'Intestin group].
    Flamenbaum M; Zénut M; Aublet-Cuvelier B; Larpent JL; Fabre P; Abergel A; Dapoigny M; Bommelaer G
    Gastroenterol Clin Biol; 1997; 21(6-7):491-6. PubMed ID: 9295977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of uveitis on the phenotype of patients with recent inflammatory back pain: data from a prospective multicenter French cohort.
    Wendling D; Prati C; Demattei C; Miceli-Richard C; Daures JP; Dougados M
    Arthritis Care Res (Hoboken); 2012 Jul; 64(7):1089-93. PubMed ID: 22354889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.